Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

NCT05599412 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic ALK+ Non Small Cell Lung Cancer

Interventions

DRUG: Lorviqua

Sponsor

Pfizer